At baseline, an appointment will be made for the following visit and an appointment for a telephone call after 4 weeks. During this call, patients will be asked if they had any complaint which started after inclusion to this study. For stimulating compliance, patients will be asked how they use their tablets. When this is different from described in this protocol, patients will be advised accordingly. Furthermore, patients will be able to ask any question during this telephone call.